Jessica Zhan's competencies
Practice Area | Jurisdiction | Rank | Agg. Deals Value | Clients Dimension | N. of Transactions | Last Quarter |
---|---|---|---|---|---|---|
Debt Capital Markets | HONG KONG | 9 | 6550 | 1858 | 6 | |
Equity Capital Markets | HONG KONG | 11 | 6750 | 644 | 9 | |
Practice Area | Jurisdiction | Rank | Agg. Deals Value | Clients Dimension | N. of Transactions | Last Quarter |
Client Reviews
The Client Reviews provides a qualitative rating based on Partners' Clients feedback assessmentCommunication Skills
FusionCharts will load here.
Technical skills
FusionCharts will load here.
Efficiency
FusionCharts will load here.
Effectiveness
FusionCharts will load here.
Perceived Added Value
FusionCharts will load here.
Ranking 2022: Jessica Zhan - Maples and Calder
Ranking 2021: Jessica Zhan - Maples and Calder
Ranking 2020: Jessica Zhan - Maples and Calder
Practice Area | Agg. Deals Value | Clients Dimension | N. of Transactions | Tier |
---|---|---|---|---|
Practice Area | Agg. Deals Value | Clients Dimension | N. of Transactions | Tier |
Significant Clients
The chart shows a balanced list of the Jessica Zhan's client portfolio - based on PBV Monitor's Analyzed Transactions during last Twelve MounthsFusionCharts XT will load here!
Team
The chart shows a balanced list of counselor working with Jessica Zhan - based on PBV Monitor's analyzed transactions during last Twelve MounthsFusionCharts XT will load here!
Co-Counsel
The Chart shows a balanced list of Jessica Zhan's Co-Counsel Law Firm - based on PBV Monitor's analyzed transactions during last Twelve MounthsFusionCharts XT will load here!
Counterparts
The Chart shows a balanced list of Jessica Zhan's other Firms involved - based on PBV Monitor's analyzed transactions during last Twelve MounthsFusionCharts XT will load here!
Peer Reviews
The Peer Reviews provides a qualitative rating based on Counterparts / Referees' feedback assessmentFusionCharts will load here.
Recent experiences
XCHG Limited's Initial Public Offering10/11/2024
Dida's IPO and SEHK Listing7/4/2024
QuantumPharm's Shares Offering6/20/2024